Skip to content

A Social Network Approach for Improving Medication Assisted Treatment and HIV Prevention and Medical Care Among People Who Inject Drugs in Ukraine

A Social Network Approach for Improving Medication Assisted Treatment and HIV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05824702
Enrollment
241
Registered
2023-04-24
Start date
2023-09-20
Completion date
2025-09-01
Last updated
2025-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, Drug Treatment

Brief summary

The aim of this study is to pilot a peer education for people on medication assisted treatment (MAT). People on MAT will be trained to be peer educators and provide outreach to the educators social network members who inject drugs, some of whom will be HIV positive.

Detailed description

The, goal of the intervention is to increase medication assisted treatment (MAT) uptake and retention in order to enhance as well as HIV medical care and antiretroviral therapy (ART) adherence among those social network members who use drugs and those living with HIV who use drugs. The project will quantitatively and qualitatively assess barriers to MAT and ART uptake and adherence, while using peer educators to promote MAT and ART among their network members. Finally, the project aims to determine the effect size for guiding the planning of larger intervention and the feasibility and acceptability of this intervention for HIV prevention and improvement in HIV-related health outcomes among people living with HIV who inject drugs (PLWH PWID). The intervention will be deployed in Ukraine, a setting with high HIV incidence rates among PWID, low levels of viral suppression among HIV positive PWID, and low rates of MAT uptake.

Interventions

BEHAVIORALPeer education & communications

The intervention trains peer educators to promote medication-assisted drug treatment among peer who inject drugs and are living with HIV.

BEHAVIORALStandard of care educational

This is an educational equal attention control group

Sponsors

Ukrainian Institute on Public Health Policy
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants are not aware of the other condition

Intervention model description

A pilot randomized clinical trial of behavioral intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* On methadone for at least 1 year and rated by the staff as low risk for relapse * Report at least 1 drug network member living with HIV, not on methadone, and seen weekly * Willing to talk with drug users in their network about medication for drug dependence and accompany them to methadone clinic

Exclusion criteria

• Persons that are currently psychotic, suicidal, or cognitively impaired such that they cannot provide informed consent will be excluded from participation.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Enrolled in drug treatment3 monthsEnrollment in drug treatment among social network members living with HIV

Countries

Ukraine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026